Vivani Medical appoints Anthony Baldor as CFO, Brigid Makes resigns

Vivani Medical, Inc.

CFO Brigid Makes resigns effective June 15, 2025; no disagreement with company.
Anthony Baldor appointed CFO, Principal Financial Officer and Principal Accounting Officer effective June 15, 2025.
Baldor previously CFO at Diakonos Oncology and VP at 4D Molecular Therapeutics.
Baldor receives $450,000 base salary, performance bonus, and option for 600,000 shares vesting over 4 years.
Makes will serve in advisory capacity during transition.

item 5.02item 7.01item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Anthony Baldor

Chief Financial Officer

VANI · Vivani Medical, Inc.

Effective: 2025-06-15
Filed: Jun 11, 2025 23:59 UTC

On June 11, 2025, the board of directors (the “Board”) of the Company appointed Anthony Baldor, to serve as the Company’s Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, effective June 15, 2025.

Departed

Brigid Makes

Chief Financial Officer

VANI · Vivani Medical, Inc.

Effective: 2025-06-15
Successor: Anthony Baldor
Filed: Jun 11, 2025 23:59 UTC

On June 10, 2025, Brigid Makes notified Vivani Medical, Inc. (the “Company”) of her decision to resign from her role as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, of the Company, effective as of June 15, 2025.

Source: SEC EDGAR

accession 0001753926-25-000956

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.